| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |